At SightMD, we are proud to offer iDose, one of the most exciting advancements in glaucoma management. iDose is a tiny, sustained-release implant that delivers long-term medication to help control intraocular pressure (IOP), often replacing the need for daily eye drops. This FDA-approved treatment provides a convenient, effective alternative for patients seeking more consistent IOP control and freedom from the burden of topical therapies.
What is iDose?
iDose (iDose TR) is a micro-invasive implant placed directly into the eye, designed to continuously release medication over months or even years. The implant delivers travoprost, a commonly prescribed prostaglandin analog, to lower IOP in patients with open-angle glaucoma or ocular hypertension. It is typically implanted during a quick, outpatient procedure and remains in the eye permanently, offering sustained IOP control without the need for daily drops.
Who is iDose for?
iDose is ideal for:
- Patients with open-angle glaucoma or ocular hypertension
- Individuals struggling to adhere to daily drop regimens
- Patients experiencing side effects from topical drops
- Those seeking long-term IOP control with fewer medications
Your SightMD ophthalmologist will conduct a comprehensive eye exam and evaluate your medical history to determine if iDose is right for you.
Benefits of iDose
- Consistent IOP Control: Delivers a steady dose of medication for more stable eye pressure.
- Drop-Free Convenience: Reduces or eliminates the need for daily glaucoma drops.
- Long-Term Effectiveness: Can last for several years.
- Reduced Side Effects: Avoids the preservatives found in many eye drops, reducing irritation and allergic reactions.
- Minimally Invasive Procedure: Implantation is quick and performed in an outpatient setting.
The Procedure: What to Expect
Implantation of iDose is typically performed in an ambulatory surgical center under local anesthesia. The procedure takes just a few minutes:
- Your eye is numbed with anesthetic drops.
- Using a preloaded injector, your surgeon places the iDose implant into the trabecular meshwork of the eye.
- There are no incisions or stitches required.
You may experience minor irritation or blurred vision immediately after the procedure, but most patients return to normal activities within a day or two.
Follow-Up and Monitoring
After iDose implantation, your doctor will monitor your IOP and overall eye health with regular follow-up visits. Most patients experience a significant reduction in eye pressure and a decrease in the number of medications needed.
Is iDose Covered by Insurance?
Many commercial insurers and Medicare plans cover the cost of iDose. Our staff will help you verify coverage and provide information about any potential out-of-pocket costs.
FAQs About iDose
Q: How long does the iDose implant last?
A: While the exact duration may vary by patient, iDose is designed to provide years of continuous medication release.
Q: Can iDose be removed or replaced?
A: iDose is designed to remain in the eye permanently. If necessary, your surgeon can evaluate options for additional treatments.
Q: Will I feel the implant in my eye?
A: No, patients do not feel the implant once it is placed.
Q: Is there a recovery period?
A: Most patients resume normal activities the next day. Some may experience temporary discomfort or blurred vision.
Q: Does iDose work for all types of glaucoma?
A: iDose is specifically designed for patients with open-angle glaucoma or ocular hypertension.
Take the Next Step If you’re tired of daily drops and looking for a more reliable way to manage glaucoma, iDose could be the answer. At SightMD, our experienced glaucoma specialists will guide you every step of the way to ensure the best outcome for your vision.